Evidence map›Paper›PMID 41954725›Full record

ArticlePhotochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology2026

Stabilization of 5-aminolevulinic acid by cucurbit[7]uril complex with enhanced fluorescence detection and photodynamic therapy of breast cancer in vitro and in a CAM model.

Sofía Pérez Del Pino, Walther Brown, Daniel Guerra Díaz, Daniel Zúñiga-Núñez, Paula S Rivero-Jerez, Daniel Pino, Hilde Harb Buzza, Denis Fuentealba

Abstract read
PubMed Publisher
In one paragraph

Article in Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sofía Pérez Del PinoLaboratorio de Química Supramolecular y Fotobiología, Departamento de Química Física, Escuela de Química, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Santiago, Chile.
Walther BrownLaboratorio de Química Supramolecular y Fotobiología, Departamento de Química Física, Escuela de Química, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Santiago, Chile.
Daniel Guerra DíazDepartamento de Química Orgánica, Facultad de Ciencias, Universidad de Chile, Santiago, Chile.
Daniel Zúñiga-NúñezLaboratorio de Química Supramolecular y Fotobiología, Departamento de Química Física, Escuela de Química, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Santiago, Chile.
Paula S Rivero-JerezLaboratorio de Química Supramolecular y Fotobiología, Departamento de Química Física, Escuela de Química, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Santiago, Chile.
Daniel PinoInstitute of Physics, Pontificia Universidad Católica de Chile, Santiago, Chile.
Hilde Harb BuzzaInstitute of Physics, Pontificia Universidad Católica de Chile, Santiago, Chile. hilde.buzza@uc.cl.ORCID http://orcid.org/0000-0002-1885-5897
Denis FuentealbaLaboratorio de Química Supramolecular y Fotobiología, Departamento de Química Física, Escuela de Química, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Santiago, Chile. dlfuente@uc.cl.ORCID http://orcid.org/0000-0003-4798-7204

Funding

Agencia Nacional de Investigación y Desarrollo 1241088Agencia Nacional de Investigación y Desarrollo 1251176
6 · The paper itself

Abstract

The FDA-approved prodrug 5-aminolevulinic acid (ALA) is efficiently metabolized by cancer cells into protoporphyrin IX (PpIX), a potent photosensitizer widely used in photodynamic therapy (PDT) and fluorescence-guided tumor surgery. However, the poor membrane permeability of ALA led to the development of more lipophilic derivatives, such as the methyl (ALAm) and hexyl (ALAh) esters. Despite improved cellular uptake, ALA and its esters are highly unstable at physiological pH, resulting in premature decomposition, reduced PpIX accumulation, and limited therapeutic efficacy. In this study, the encapsulation of ALA, ALAm, and ALAh within cucurbit[7]uril (CB[7]) was evaluated as a strategy to enhance their stability and performance. Complex formation was confirmed by isothermal titration calorimetry,

Indexed as

Aminolevulinic AcidBreast NeoplasmsBridged-Ring CompoundsImidazolesPhotochemotherapyPhotosensitizing AgentsAnimalsCell SurvivalChick EmbryoCucurbit(n)urilsDrug StabilityFemaleFluorescenceHumansMacrocyclic CompoundsMCF-7 CellsAminolevulinic AcidBridged-Ring Compoundscucurbit(7)urilCucurbit(n)urilsImidazolesMacrocyclic CompoundsPhotosensitizing Agents5-aminolevulinic acidCucurbit[7]urilFluorescence detectionPhotodynamic therapyProtoporphyrin IX

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.